ASX:ANN
Ansell Limited · ASX · Healthcare · AUD · FY for 2026
Figures on this page computed 2026-11-08 12:25 UTC
Last close
n/aAUD
Market data
20.9xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- AUD
- computed
- Computed from the filing for 2026
10.1%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- AUD
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
9.8%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- AUD
- Computed from the filing for 2026
- Computed from the filing for 2026
13.9%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- AUD
- Computed from the filing for 2026
- Computed from the filing for 2026
0.38Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- AUD
- Computed from the filing for 2026
- Computed from the filing for 2026
1.8%Dividend yield
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- AUD
- computed
Growth is the furthest below its sector's middle: 0.41 against 0.47 on the market's range.
Then and now
lens 3 of 9| Fact | 2009 | 2026 | Change |
|---|---|---|---|
| Sales | 1,080,923,500 | 2,140,200,000 | +98% |
| Profit | 78,325,982 | 208,600,000 | +166% |
| Free cash flow | 93,304,046 | 298,500,000 | +220% |
| Debt | 254,978,601 | 756,600,000 | +197% |
| Shares in issue | 137,955,000 | 143,800,000 | +4.2% |
The same five facts for 2009 and 2026, each read from the year's own filing.
The same five facts for 2009 and 2026, each read from the year's own filing.
Every figure in this lens
Except where said otherwise: Computed from the filing for 2009
Sales, 20091,080,923,500
- Source
- computed
- Statement
- income
- Fiscal year
- 2009
- Reported in
- USD
Sales, 20262,140,200,000Computed from the filing for 2026
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- USD
Profit, 200978,325,982
- Source
- computed
- Statement
- income
- Fiscal year
- 2009
- Reported in
- USD
Profit, 2026208,600,000Computed from the filing for 2026
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- USD
Free cash flow, 200993,304,046
- Source
- computed
- Statement
- income
- Fiscal year
- 2009
- Reported in
- USD
Free cash flow, 2026298,500,000Computed from the filing for 2026
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- USD
Debt, 2009254,978,601
- Source
- computed
- Statement
- income
- Fiscal year
- 2009
- Reported in
- USD
Debt, 2026756,600,000Computed from the filing for 2026
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- USD
Shares in issue, 2009137,955,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2009
- Reported in
- USD
Shares in issue, 2026143,800,000Computed from the filing for 2026
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- USD